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Abstract. 
 
The tumor suppressor gene p16
 
INK4a
 
 inhibits
the kinase activity of the cyclin-dependent kinase 4–6/
cyclin D complexes and subsequent phosphorylation of
critical substrates necessary for transit through the G1
phase of the cell cycle. Recent studies suggested that
 
control of the G1/S boundary might not be the sole
biological function of p16
 
INK4a
 
. We hypothesized that
p16
 
INK4a 
 
might inﬂuence hitherto unknown critical fea-
tures of a malignant epithelial phenotype, such as an-
chorage dependence. Here we provide evidence that
stable transfection of p16
 
INK4a
 
 restitutes apoptosis in-
duction upon loss of anchorage (anoikis) in a variety of
human cancer cells. Anoikis in p16
 
INK4a
 
-transfected
cells was evidenced by DNA fragmentation and
poly(ADP-ribose) polymerase cleavage upon cultiva-
tion on polyhydroxyethylmethacrylate-coated dishes
and was associated with suppression of anchorage-inde-
pendent growth as well as complete loss of tumorige-
nicity. p16
 
INK4a
 
-mediated anoikis was due to selective
transcriptional upregulation of the 
 
a
 
5
 
 integrin chain of
the 
 
a
 
5
 
b
 
1
 
 ﬁbronectin receptor as detected by FACS
 
®
 
analysis, immunoprecipitation, Northern blotting, and
nuclear run-on assays. Addition of soluble ﬁbronectin
and inhibitory 
 
a
 
5
 
 antibodies to nonadherent cells com-
pletely abolished p16
 
INK4a
 
-mediated anoikis, whereas
 
laminin was ineffective. Furthermore, antisense-induced
downregulation of the 
 
a
 
5
 
 integrin chain in p16
 
INK4a
 
-
transfected cells restored resistance to anoikis. These
data suggest a novel functional interference between a
cell cycle–regulating tumor suppressor gene and mem-
brane-bound integrins, thus regulating a hallmark fea-
ture of an epithelial transformed phenotype: suscepti-
bility to anoikis.
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Introduction
 
The tumor suppressor p16
 
INK4a
 
, inhibitor of cyclin-depen-
dent kinase (Cdk)
 
1 
 
4, represents a major target in human
carcinogenesis (Okamoto et al., 1994). Functional inacti-
vation of p16
 
INK4a
 
 has been described in a wide variety of
human malignancies and transformed cell lines (Serrano,
1997). Underlying mechanisms involved in p16
 
INK4a
 
 inacti-
vation comprise homozygous deletions, intragenic muta-
tions, and transcriptional silencing due to promoter hyper-
methylation (Yang et al., 1995; Liggett and Sidransky,
1998; Caldas et al., 1994). In contrast to p16
 
INK4a
 
, other
members of the INK4 family (p15
 
INK4b
 
, p18
 
INK4c
 
, and
p19
 
INK4d
 
) play minor roles in tumorigenesis (Schwaller et
 
al., 1997). The p16
 
INK4a
 
 gene, which is located on chromo-
some 9p21, encodes a protein of 156 amino acids compris-
ing 4 ankyrin repeats. The main biological function of
p16
 
INK4a
 
 involves regulation of cell cycle progression at the
G1/S boundary (for review see Ruas and Peters, 1998). Pro-
gression through G1 requires Cdk4–6/cyclin D–dependent
phosphorylation of the retinoblastoma protein (Rb) and
the related “pocket proteins,” p107 and p130, resulting in
liberation of associated transcription factors necessary for
DNA replication during S phase of the cell cycle. p16
 
INK4a
 
acts in the so termed p16
 
INK4a
 
/Cdk4/cyclin D1/Rb pathway
by selectively binding to and inhibiting Cdk4–6, thus pre-
venting pRb phosphorylation and resulting in cell cycle ar-
rest at the G1 checkpoint (Sherr, 1996; Serrano, 1997).
Recent experimental evidence suggested additional bio-
logical functions for p16
 
INK4a
 
. Apart from cell cycle con-
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trol, p16
 
INK4a
 
 has been implicated in other fundamental
cellular processes, such as angiogenesis (Harada et al.,
1999), cell senescence (Votja and Barrett, 1995), tumor in-
vasion (Chintala et al., 1997), cell spreading (Fåhraeus and
Lane, 1999), and apoptosis (Sandig et al., 1997; Naruse et
al., 1998). In part, p16
 
INK4a
 
 elicits such pleiotropic effects
by modulating the expression or function of distinct key
target molecules like vascular endothethial growth factor
(Harada et al., 1999), matrix metalloproteinase 2 (Chintala
et al., 1997), nuclear factor 
 
k
 
B (Wolff and Naumann,
1999), 
 
b
 
1,4-galactosyltransferase (Zhang et al., 1999), inte-
grin 
 
a
 
v
 
b
 
3 
 
(Fåhraeus and Lane, 1999), or pRb (Fang et al.,
1998).
In contrast to their malignant counterparts, nontrans-
formed epithelial cells will undergo apoptosis when they
lose contact with their underlying matrix. In a physiologi-
cal context, this phenomenon is observed in normal skin
(Polakowska et al., 1994), colonic epithelium (Hall et al.,
1994), and in the involuting mammary gland (Boudreau et
al., 1995). Induction of apoptosis upon loss of anchorage
has been termed anoikis (Greek for homelessness) (Frisch
and Ruoslahti, 1997) and has been shown to occur in epi-
thelial (Frisch and Francis, 1994) and endothelial cells
(Meredith et al., 1993). Anoikis can be considered as a
safety program for the organism, which prevents survival
and reattachment of detached cells to new matrices at in-
adequate locations. During malignant transformation,
most epithelial cells will become resistant to anoikis,
thereby gaining an important growth advantage and pro-
viding the basis for tumor spread, growth at distant places,
and formation of metastasis.
Integrins, which are large glycoproteins that function as
transmembrane receptors, mediate cell adhesion to extra-
cellular matrix and participate in signal transduction. They
are involved in the regulation of complex biological pro-
cesses such as angiogenesis, tumor cell migration, invasion,
and metastasis (Hynes, 1992; Schwartz et al., 1995). Fur-
thermore, they were identified as central mediators of
anoikis in several cell types (Varner and Cheresh, 1996;
Frisch and Ruoslahti, 1997). Currently, 8 
 
b
 
 and 17 
 
a
 
 inte-
grin subunits have been characterized that associate with
heterodimers and generate 
 
.
 
20 different integrins (Lafre-
nie and Yamada, 1996). The integrin 
 
a
 
5
 
b
 
1 
 
represents a spe-
cific fibronectin receptor which plays a central role in
anchorage-dependent survival and apoptosis and is fre-
quently lost or down-regulated in transformed cells. Con-
versely, ectopic expression of integrin 
 
a
 
5
 
b
 
1 
 
has been dem-
onstrated to regulate tumor cell proliferation in vitro as
well as tumor growth in vivo (Giancotti and Ruoslahti,
1990; Symington, 1990; Varner et al., 1995).
We now provide evidence that the tumor suppressor
p16
 
INK4a 
 
induces anoikis via a novel mechanism involving
upregulation of the fibronectin receptor 
 
a
 
5
 
b
 
1
 
.
 
Materials and Methods
 
Cell Culture
 
The human pancreatic carcinoma cell line Capan-1 (HTB 79; American
Type Culture Collection) was grown in monolayer cultures in RPMI me-
dium (Life Technologies) supplemented with 15% fetal calf serum (Bio-
chrom), 2 mM glutamine, 100 U/ml penicillin, and 100 
 
m
 
g/ml streptomycin
in a humidified atmosphere containing 5% CO
 
2
 
 at 37
 
8
 
C. The human mela-
 
noma cell line NKI4, donated by Dr. J. Eberle (Freie Universität Berlin,
Universitätsklinikum der Freien Universität Berlin, Berlin, Germany),
and Madin-Darby canine kidney (MDCK, CCL-34; American Type Cul-
ture Collection) cells were cultivated in DMEM medium (Life Technolo-
gies) supplemented with 10% fetal calf serum.
 
 
 
The human hepatocellular
carcinoma cell line SKHep1, provided by Dr. D. Schuppan (University of
Erlangen, Erlangen, Germany), was cultivated in RPMI medium supple-
mented with 20% fetal calf serum.
 
Generation of Stably Transfected p16
 
INK4a
 
-expressing 
Cell Clones
 
Full-length human-p16
 
INK4a
 
 cDNA was subcloned into the eukaryotic ex-
pression vector pRC/CMV (Invitrogen), where p16
 
INK4a
 
 is under control
of the CMV promoter and can be selected by neomycin resistance. Trans-
fections were done using lipofectamine (Life Technologies), which gener-
ated liposome complexes. For stable transfections, 5 
 
m
 
g plasmid and 30 
 
m
 
l
lipofectamine were incubated in 1.6 ml medium for 45 min at room tem-
perature. 10
 
6
 
 cells plated on a 10-cm dish were exposed to the formed lipo-
some complexes diluted in 8 ml medium for 6 h. Cells were washed and
maintained in fresh medium overnight. After trypsinization, resuspended
cells were portioned into three 20-cm dishes and selection was done with
G418 (Life Technologies; 1 mg/ml for Capan-1 and MDCK, 0.4 mg/ml for
NKI4, and 1.5 mg/ml for SKHep1) for 3 wk. Independent stable clones
were isolated and cultivated in the presence of G418. The vector pRC/
CMV without insert was stably transfected in parallel to generate mock-
transfected control clones. Downregulation of the 
 
a
 
5
 
 integrin chain in
p16
 
INK4a
 
-expressing cells was done by cotransfecting the plasmid pCMV5
 
9
a
 
5 
 
antisense (provided by B. von Lampe, Freie Universität Berlin, Univer-
sitätsklinikum der Freien Universität Berlin, Berlin, Germany), which
contains human 
 
a
 
5 
 
antisense cDNA and the expression vector pIRES1-
hyg (CLONTECH Laboratories, Inc.), and can be selected by hygromycin
resistance. 12 
 
m
 
g of each plasmid and 120 
 
m
 
l lipofectamine were incubated
for 45 min at room temperature in 6 ml media. Liposome complexes were
diluted in 20 ml media and added to 1.5 
 
3
 
 10
 
7
 
 cells plated the day before
on a 20-cm dish. Transfected cells were selected in the presence of 0.1 mg/
ml hygromycin (Life Technologies) and 1 mg/ml G418.
 
Immunoprecipitation and Western Blot Analysis
 
Cells grown to subconfluency were lysed in 50 mM Hepes, pH 7.4, 150
mM sodium chloride, 1 mM EDTA, 2.5 mM EGTA, 10% glycerol, 0.1%
Tween 20, 1 mM DTT, 1 mM sodium fluoride, 10 mM 
 
b
 
-glycerolphos-
phate, 0.1 mM sodium orthovanadate, 0.1 mM PMSF, 3 
 
m
 
g/ml aprotinin,
and 2 
 
m
 
M leupeptin. Cell lysates were immunoprecipitated with rabbit
anti–human Cdk4 pAb (Santa Cruz Biotechnology, Inc.), and immune
complexes were recovered with protein A–Sepharose beads (Sigma-
Aldrich) overnight at 4
 
8
 
C. Equal amounts of immunoprecipitated pro-
teins were separated on SDS-PAGE gels and electroblotted to PVDF
membranes (NEN Life Science Products). Membranes were sequentially
probed with a monospecific mouse anti–human anti-p16
 
INK4a
 
 antibody (fi-
nal dilution 1:1,000; Neomarkers) or anti-Cdk4 antibody (1:1,000; BD
PharMingen) overnight at 4
 
8
 
C. After exposure for 2 h at room tempera-
ture to secondary goat anti–mouse horseradish peroxidase–conjugated an-
tibody (1:20,000; Dako), protein bands were visualized using the ECL sys-
tem (Amersham Pharmacia Biotech).
 
Anchorage-independent Growth Assays
 
For evaluation of anchorage-independent growth, cells were analyzed in a
human tumor clonogenic assay. 10
 
3
 
 cells were diluted in 1 ml methylcellu-
lose/agar mixture resolved in Iscove’s medium (Life Technologies) sup-
plemented with 27% fetal bovine serum (HyClone). Cells were plated in
triplicates on 3-cm dishes and incubated for 12 d. Only cell aggregates of
 
.
 
20 cells were evaluated, and vital colonies were counted with an in-
verted light microscope.
 
Tumor Growth in Nude Mice
 
Female inbred Swiss 
 
nu/nu
 
 mice weighing 
 
z
 
25 g were obtained from
Charles River Laboratories. Animals were purchased as specific pathogen
free and received water and food ad libitum. Mice were subcutaneously
injected with 1.5 
 
3
 
 10
 
6
 
 Capan-1 cells into the right inguinal fat pad. Each
experimental group consisted of at least seven animals. Tumor-bearing
mice were examined for palpable primary tumors twice weekly. Growth 
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of tumors was determined by caliper measurements of the largest diame-
ter and its perpendicular. Tumor size was calculated as: tumor volume
(mm
 
3
 
) 
 
5 
 
0.5 
 
3
 
 
 
a
 
 
 
3
 
 
 
b
 
2
 
, where 
 
a
 
 is the largest diameter and 
 
b
 
 is its perpen-
dicular. Two independent experiments were performed to ensure the re-
producibility of the results. Tumors were embedded in paraffin. The lung,
the liver, and the spleen were removed and fixed in Bouin’s solution to
identify potential metastatic tumor spread.
 
In Situ Apoptosis Detection
 
Detection of apoptotic cells in mouse xenografts was performed using the
TACS in situ apoptosis detection kit (Genzyme), following the manufac-
turer’s instructions. In brief, after deparaffinization of tissues, apoptoti-
cally generated DNA fragments were labeled by incorporation of biotin-
ylated nucleotides using terminal deoxynucleotidyl transferase in a buffer
including manganese. Incorporated biotinylated nucleotides were de-
tected using a streptavidin–horseradish peroxidase conjugate with DAB
as a substrate, which produces a brown color in apoptotic cells. Intact cells
were counterstained with methyl green.
 
Analysis of Integrin Expression by Flow Cytometry
 
10
 
6
 
 cells were resuspended in 100
 
 
 
m
 
l PBS containing the appropriate dilu-
tions of subunit-specific integrin antibodies (
 
a
 
1
 
 [1:20; T-Cell Sciences], 
 
a
 
2
 
[1:100; dianova], 
 
a
 
3
 
 [1:20; Oncogene], 
 
a
 
4
 
 [1:100; dianova], 
 
a
 
5
 
 [1:50; Dako;
clone P1D6], 
 
a
 
6
 
 [1:25; dianova], 
 
a
 
v
 
 [1:100; dianova], 
 
b
 
1
 
 [1:50; dianova], 
 
b
 
3
 
[1:75; dianova], 
 
b
 
4
 
 [1:100; Telios], and 
 
b
 
5
 
 [1:100; dianova]). After incuba-
tion for 15 min at 4
 
8
 
C, cells were washed with PBS and incubated with a
secondary FITC-conjugated antibody (goat anti–mouse FITC, 1:50;
Sigma-Aldrich) or for 
 
a
 
6
 
 integrin subunit with rabbit anti–rat FITC (1:50;
Sigma-Aldrich). Integrin expression levels compared with mouse Ig con-
trol antibody (1:100; Dako) were then determined by flow cytometry us-
ing a FACSCalibur™ (Becton Dickinson). Evaluation was done using the
CellQUEST™ program (Becton Dickinson).
 
a
 
5 
 
Integrin Immunoprecipitation
 
10
 
7
 
 cells were incubated with 1 
 
m
 
g/
 
m
 
l biotin-
 
e
 
-aminocaproic acid 
 
N
 
-hydroxy-
succinimide ester (Boehringer) for 5 min at room temperature in labeling
buffer (137 mM NaCl, 5 mM KCl, 6 mM NaHCO
 
3
 
, 1.5 mM CaCl
 
2
 
, 0.8 mM
MgSO
 
4
 
, and 1 g/liter glucose) for 5 min at room temperature and lysed in
50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.5% NP-40, 1 mM CaCl
 
2
 
, 2 mM
PMSF, 1 mM aprotinin, 1 mM leupeptin, and 1 mM pepstatin A. Biotin-
ylated protein lysate (100 
 
m
 
g) was immunoprecipitated by integrin anti-a5
antibody P1D6 (Dako) using rabbit anti–mouse IgG conjugated to protein
A–Sepharose (Sigma-Aldrich). Extensively washed immunoprecipitates
were separated on SDS-PAGE gel and electroblotted to PVDF mem-
branes. Biotinylated protein bands were detected by streptavidin–horse-
radish peroxidase (Sigma-Aldrich) and visualized using the ECL system
(Amersham Pharmacia Biotech).
a5 Integrin Northern Blot
mRNA was isolated from Capan-1 cells with a Poly A1 tract kit
(Promega) according to the manufacturer’s protocol. Purified RNA was
quantified by spectrophotometric measurement. 5 mg of each sample was
separated on a 1% agarose/MOPS/formaldehyde gel. After electrophore-
sis, gels were capillary blotted overnight to Hybond-N filters (Amersham
Pharmacia Biotech). RNA was then immobilized by UV cross-linking.
The vector pcDNA3/a5 containing full-length human a5 cDNA, was pro-
vided by Dr. K. Schramm (Freie Universität Berlin, Universitätsklinikum
der Freien Universität Berlin, Berlin, Germany). The a5 insert was re-
leased by HindIII digestion, purified by gel extraction, and randomly la-
beled with [a-32P]dCTP using a Megaprime DNA labeling kit (Amersham
Pharmacia Biotech). The cDNA probe was purified on a Sephadex G-50
column to remove unincorporated nucleotides. Hybridization was carried
out at 658C with Quick-Hyb buffer (Stratagene). Membranes were washed
at 658C using a stringency of 0.13 SSC, 0.1% SDS, and exposed to x-ray
films at 2808C.
a5 Integrin Nuclear Run-on
Nuclear run-on transcription was performed as described previously by
Rosewicz et al. (1994). In brief, nuclei from 108 cells were purified by cen-
trifugation through a sucrose cushion. Transcribed RNA products labeled
through [a-32P]UTP incorporation were purified by DNase I treatment,
proteinase K digestion, phenol/chloroform extraction, and propanol pre-
cipitations. Unincorporated nucleotides were removed using the RNeasy
mini kit (QIAGEN). Equal counts (5 3 106 cpm) of run-on probe were
hybridized at 428C for 48 h to cDNAs of p16INK4a, glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH), and a5 integrin subunit (5 mg/slot) dena-
tured at 658C in 0.2 M NaOH before slot blotting on nitrocellulose mem-
branes and immobilization by UV cross-linking. Supplementation of
a-amanitin (2 mg/ml) was used as control for transcription specificity. Af-
ter hybridization, membranes were washed with 23 SSC at 608C for 1 h,
then 23 SSC with RNase A (100 mg/ml) at 378C for 30 min, and a final
wash with 23 SSC and 0.5% SDS at 378C for 1 h. Membranes were ex-
posed to x-ray films at 2808C.
Induction of Anoikis
To prevent cell adhesion, 6-well plates were covered with a solution of
polyhydroxyethylmethacrylate (polyHEMA; Sigma-Aldrich), dissolved at
10 mg/ml in ethanol. To coat 6-well plates, 3 ml of polyHEMA solution
was added to each well. Plates were kept at 378C for at least 3 d until the
solvent had completely evaporated. To induce anoikis, 5 3 105 resus-
pended cells were cultured in RPMI medium containing 15% fetal calf se-
rum for 20 h on polyHEMA-coated dishes at 378C and 5% CO2. Subse-
quently, cells were gently recovered and submitted to apoptosis detection
assays.
Determination of Apoptotic Cells by Flow Cytometry
Cells were fixed with ice-cold ethanol (70% final concentration), resus-
pended in 0.5 ml solution of 20 mg/ml propidium iodide and 200 mg/ml
DNase-free RNase in PBS, and incubated for 30 min at 378C. For flow cy-
tometric analysis, at least 10,000 cells were evaluated using a FACSCali-
bur™. Cell cycle distribution and pre-G1 fraction were determined and
quantitated using the CellQUEST™ program.
Poly(ADP-Ribose) Polymerase Western Blot
106 Capan-1 cells were lysed in 60 mM Tris-HCl, pH 6.8, 6 M urea, 10%
glycerol, 2% SDS, 5% b-mercaptoethanol, 0.001% bromphenol blue, son-
icated for 15 s, and incubated at 658C for 15 min. Whole cell lysates were
separated on a 10% SDS-PAGE gel. Full-length poly(ADP-ribose) poly-
merase (PARP) and the apoptosis-related cleavage fragment were de-
tected by Western blotting with a monospecific mouse anti–human PARP
antibody (1:100; Calbiochem) and visualized as described above (see
Western blot analysis).
DNA Fragmentation
106 Capan-1 cells were lysed in 10 mM Tris-HCl, pH 8.2, 400 mM sodium
chloride, 2 mM EDTA containing 1% SDS, and 50 mg/ml proteinase K.
DNA was precipitated with ethanol, washed, dried, and resolved in TE
buffer containing 50 mg/ml RNase A. Equal amounts of DNA (1 mg) were
electrophoresed in a 1% agarose gel. Fragmented DNA was stained with
ethidium bromide, visualized under UV light, and photographed. A 100-bp
DNA ladder was electrophoresed in parallel for size determination.
Anoikis Protection Assay
To verify the specificity of the a5 integrin–mediated effect on anoikis, 5 3
105 cells plated on polyHEMA-coated dishes were treated with various
concentrations of soluble fibronectin, laminin (Sigma-Aldrich), or an in-
hibitory a5 integrin antibody (10 mg/ml; Biomol). After 20 h incubation,
anoikis was examined by FACS® analysis.
Results
Stable Transfection of p16INK4a Results in Binding
to Cdk4
After stable transfection of human p16INK4a cDNA into
the human pancreatic cell line Capan-1, 20 independently
isolated p16INK4a-positive clones were generated. All
clones showed similar p16INK4a protein expression levels in
Western blot analysis (data not shown). Therefore, threeThe Journal of Cell Biology, Volume 150, 2000 1470
p16INK4a-positive clones, designated p16/1, p16/2 and p16/3,
were randomly selected for further investigations. As
shown in Fig. 1 A, the functional integrity of the expressed
protein was confirmed based on its ability to bind Cdk4 by
using Cdk4 immunoprecipitation followed by Western
blot detection with a monospecific p16INK4a antibody.
p16INK4a Inhibits Anchorage-independent Growth
Cell–cell and cell–matrix interactions impose stringent
control on normal, but not transformed, epithelial cells.
Colony formation assays exploit the disruption of these
contacts by isolation and immobilization of cells in soft
agar to specifically monitor properties of the transformed
phenotype. Therefore, effects of p16INK4a reexpression on
anchorage-independent cell growth were evaluated by
monitoring colony formation in soft agar. Reexpression of
p16INK4a reduced the number of viable colonies to 20–25%
compared with controls (Fig. 1 B). At microscopic exami-
nation, a large fraction of p16INK4a-transfected cells shrank
and displayed fragmented nuclei after few days, suggesting
induction of apoptosis rather than prolonged cell cycle ar-
rest.
p16INK4a Confers Loss of Tumorigenicity in Nude Mice
To directly evaluate the role of p16INK4a for tumor forma-
tion in vivo, we xenotransplanted p16INK4a-transfected and
p16INK4a-negative cells into nude mice. Mice treated with
parental and mock-transfected cells developed solid tu-
mors with a take rate of 100% (n 5 42), and an average tu-
mor volume of 150 cmm 3 wk after injection. In striking
contrast, no measurable tumor formation occurred in mice
that received p16INK4a-expressing tumor cells (n 5 40)
(Fig. 2 A). These results were confirmed in two indepen-
dent experiments.
To follow up the fate of p16INK4a-expressing cells, we in-
vestigated the subcutaneously injected cells for the pres-
ence of apoptosis 2 d after xenotransplantation. Paraffin-
embedded tissues were screened for apoptotic cells using
the terminal deoxynucleotidyl transferase–mediated
dUTP biotin nick end labeling (TUNEL) technique (Fig. 2
B). Whereas p16INK4a-negative control cells formed ade-
nocarcinomas without evidence of relevant apoptosis,
p16INK4a-positive cells failed to organize into tumor struc-
tures but instead underwent massive cell death due to ap-
optosis.
p16INK4a Induces Anoikis In Vitro
Since matrix detachment represented a potential trigger
for the apoptosis induction observed in vivo, this hypothe-
Figure 1. p16INK4a inhibits anchorage-independent growth. (A)
Human full-length p16INK4a cDNA was cloned into the eukary-
otic expression vector pRC/CMV and stably transfected in Ca-
pan-1 cells. Three randomly selected p16INK4a-positive clones
(p16/1,2,3) were chosen for further experiments. Cdk4 was im-
munoprecipitated from whole cell lysates of either control or
p16INK4-expressing clones. Immunoprecipitates were then ana-
lyzed by Western blotting using monospecific antibodies against
p16INK4a and Cdk4. (B) Anchorage-independent growth was ex-
amined using a soft agar colony formation assay. 103 cells were
seeded in a methylcellulose/agar mixture and incubated for 12 d.
Vital colonies of .20 cells were counted using a microscope.
Shown are the mean 6 SEM of three independent experiments,
each performed in triplicates.
Figure 2. Tumorigenicity in vivo. (A) Nude mice were subcuta-
neously injected with 2 3 106 Capan-1 cells from either control
clones (d, wild-type; m, mock 1; and ., mock 2) or p16INK4-trans-
fected clones (s, p16/1; ,, p16/2; and n, p16/3). Each clone was
injected in at least six animals. Tumor growth was then moni-
tored at the indicated time points. Shown is a representative
(mean 6 SEM) of two independent experiments yielding identi-
cal results. (B) In situ apoptosis detection. Tissue sections of xe-
nografts were prepared at day 2 after cell injection. Cellular ap-
optosis was detected using the TUNEL assay as described in
Materials and Methods. Arrows indicate representative apop-
totic cells characterized by a brown color (magnification, 3100).Plath et al. p16 Mediates Anoikis via the a5b1 Fibronectin Receptor 1471
sis was tested using an in vitro anoikis assay. PolyHEMA,
due to its uniformly nonionic nature, prevents cell attach-
ment and deposition of matrix components, thus maintain-
ing cells in suspension (Folkman and Moscona, 1978).
Therefore, we examined anoikis by culturing cells on non-
adhesive polyHEMA-coated dishes and subsequently ana-
lyzed cell cycle distribution by flow cytometry. A five- to
sixfold increase of apoptosis (subdiploid DNA content in
pre-G1) was detected in p16INK4a-transfected cells (p16/1,
31%; p16/2, 33%; and p16/3, 32%) compared with controls
(wild-type, 3%, mock 1, 5%, mock 2, 8%) (Fig. 3 A) at 20 h.
Induction of anoikis was detectable as early as 3 h and in-
creased time-dependently with a maximum at 20 h after
plating on polyHEMA (data not shown). p16INK4a-medi-
ated induction of anoikis was further confirmed by apop-
tosis-specific cleavage of the mitochondrial PARP protein
(Fig. 3 B) and appearance of oligonucleosomal DNA frag-
mentation (DNA laddering) (Fig. 3 C), both of which were
virtually absent in p16INK4a-negative controls.
p16INK4a Mediates Anoikis in Different Cell Types
We next investigated whether p16INK4a-mediated induc-
tion of anoikis was cell type specific. We therefore sta-
bly transfected p16INK4a in cell lines lacking endogenous
p16INK4a from different origins such as liver (SKHep1),
skin (NKI4), and kidney (MDCK). Expression of p16INK4a
in transfected clones was confirmed by Western blotting
using p16INK4a-specific antibodies (Fig. 4 A). Upon reintro-
duction of p16INK4a, anoikis increased five- to sixfold in
Capan-1 cells. In NKI4 and SKHep1 cells, p16INK4a reex-
pression resulted in a four- to fivefold increase of anoikis
in two independent transfected cell clones compared with
parental and mock-transfected controls (Fig. 4 B). More-
over, stable transfection of p16INK4a in two MDCK cell
clones resulted in an increase of anoikis of 354 6 64%
Figure 3. Analysis of anoikis. Anoikis was examined by three dif-
ferent experimental procedures. For all experiments, 5 3 105 re-
suspended cells were plated on polyHEMA-coated dishes. After
20 h, cells were harvested and subsequently analyzed. A repre-
sentative of three independent experiments yielding identical re-
sults is shown. (A) FACS® analysis. Cells were ethanol-fixed,
stained with propidium iodide, and analyzed by flow cytometry.
The percentage of cells containing subdiploid DNA is indicated
in each panel. (B) PARP cleavage. Cell lysates were prepared
and immunoblotted with an mAb to PARP. The indicated molec-
ular mass of the full-length PARP protein and its apoptotic cleav-
age fragment were deduced from a molecular size marker elec-
trophoresed in parallel. (C) DNA laddering. From each clone,
genomic DNA was extracted and 1 mg was electrophoresed on a
1% agarose gel. Fragment sizes of the 100-bp marker are indi-
cated.
Figure 4. p16INK4a induces anoikis in cell lines from different ori-
gin. (A) p16INK4a was stably transfected into pancreatic tumor cell
line Capan-1, melanoma cell line NKI4, hepatocellular carci-
noma cell line SKHep1, and kidney cell line MDCK. Expression
of p16INK4a was confirmed by Western blotting using monospe-
cific p16INK4a antibodies. (B) For determination of anoikis, 5 3
105 cells of each control or p16INK4a-positive clone were plated on
polyHEMA-coated dishes and incubated for 6 h (MDCK), 20 h
(Capan-1 and SKHep1), or 72 h (NKI4). The amount of apop-
totic cells was subsequently determined by FACS® analysis.
Shown are the mean 6 SEM of three independent experiments,
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compared with p16INK4a-negative mock-transfected con-
trols (Fig. 4 B).
Effects of p16INK4a on Integrin Expression
Because cell–matrix interactions are critically determined
by integrins, we hypothesized that p16INK4a regulates
anoikis via modulation of integrin expression. Using a
broad panel of monospecific antibodies against various in-
tegrins in flow cytometry analysis, we compared the inte-
grin expression pattern in relation to the p16INK4a status.
Compared with isotype-matched control antibodies, Ca-
pan-1 cells expressed a1, a2, a3, a5, a6, av and b1, b4, b5 in-
tegrins, whereas no expression of the a4 and b3 integrin
subunits could be detected (Fig. 5 A). Most integrins were
equally expressed in both cell populations regardless of
the p16INK4a status. In contrast, we observed a selective
and significant increase of the a5 integrin subunit in all
p16INK4a-expressing cell clones compared with controls
(Fig. 5 A). It is noteworthy that the expression level of the
b1 subunit, which is the unique partner for a5 to form the
a5b1 fibronectin receptor and also forms heterodimers
with eight other a subunits, was not influenced by p16INK4a
(Fig. 5 A).
To confirm the increased expression of the a5 integrin
subunit observed by flow cytometry, we examined a5 ex-
pression in more detail. As revealed by immunoprecipita-
tion, Northern blotting, and nuclear run-on assays, expres-
sion of the a5integrin subunit was significantly increased
upon reintroduction of p16INK4a. Using a5 immunoprecipi-
tation of cell surface biotinylated proteins, we observed a
three- to fivefold increase of the a5 integrin chain in
p16INK4a-transfected cells compared with p16INK4a-negative
controls (Fig. 5 B). As expected, the b1 integrin subunit of
the a5b1 fibronectin receptor was coimmunoprecipitated
by the a5 antibody, reflecting the assembly of intact fi-
bronectin receptor in the transfected clones (Fig. 5 B).
Similarly, Northern blot analysis (Fig. 5 C) and nuclear
run-on experiments (Fig. 5 D) revealed three- to fourfold
increased a5 mRNA concentrations in p16INK4a-expressing
cells, indicating that reexpression of p16INK4a results in
transcriptional upregulation of the a5 integrin subunit.
Fibronectin Selectively Inhibits
p16INK4a-mediated Anoikis
To further support the hypothesis that p16INK4a induces
anoikis via upregulation of the unligated a5b1 fibronectin
receptor, the effects of fibronectin ligand on induction of
anoikis were examined. Fibronectin is the only known
ligand for integrin a5b1, but it is also recognized by other
integrins (Akiyama et al., 1995). Soluble fibronectin added
to cells plated on polyHEMA-coated dishes completely in-
hibited p16INK4a-mediated anoikis, whereas it had no effect
on wild-type or mock-transfected control cells (Fig. 6 A).
Inhibition of anoikis by soluble fibronectin occurred in a
dose-dependent manner with a maximal and complete in-
hibition at 0.3 mg/ml of soluble fibronectin (Fig. 6 B). Fur-
thermore, the anoikis inhibitory effects were specific for fi-
bronectin, as other extracellular matrix components, such
as collagen type IV (data not shown) or laminin, had no in-
fluence on anoikis (Fig. 6 A). Therefore, soluble fibronec-
tin blocked the integrin a5b1–mediated apoptotic signals in
nonadherent cells.
To further investigate the role of a5b1 integrin in
p16INK4a-mediated anoikis, we disturbed the a5b1 inte-
grin–fibronectin interaction by the addition of an inhibi-
tory anti-a5 mAb, which completely abolished soluble
fibronectin-mediated inhibition of anoikis (Fig. 6 B). Anti-
Figure 5. Analysis of integrin expression. (A) Capan-1 cells were
incubated with the indicated mAb against various a and b inte-
grin subunits and subsequently analyzed by flow cytometry. Re-
sults from three control (wild-type, mock 1/2) and three p16 (1/2/3)
clones are summarized and the mean 6 SEM of two independent
experiments is shown. (B) Biotinylated cell surface proteins were
immunoprecipitated with an a5 integrin mAb and detected using
a streptavidin-peroxidase conjugate in ECL visualization. The
size of a5 and b1 integrin subunits was deduced from markers
electrophoresed in parallel. (C) Poly A1 purified mRNA (5 mg/
lane) of the indicated cell clones was analyzed by Northern blot-
ting using a [32P]dCTP-labeled a5 integrin cDNA probe. Bands
reflecting a5 integrin mRNA (4.2 kb) and rRNAs are indicated.
As loading control, samples were stained with ethidium bromide
before blotting (bottom). (D) Nuclei were prepared from a
mock-transfected and a p16INK4a-positive clone. After in vitro
transcription in the presence of [a-32P]UTP,  32P-labeled RNA
(5 3 106 cpm) was hybridized for 48 h to cDNAs of p16INK4a,
GAPDH, and a5 integrin subunit immobilized on a nitrocellu-
lose membrane. No hybridization signal was detectable when
a-amanitin was added to the transcription reaction, confirming
the specificity of the observed hybridization signals (not shown).
One representative autoradiograph out of three independent ex-
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body-mediated impairment of a5–fibronectin interaction
dose-dependently restituted p16INK4a-dependent anoikis
(not shown). These results provide further support that
p16INK4a-mediated anoikis is directly correlated with over-
expression of the unligated fibronectin receptor a5b1.
Downregulation of the a5 Integrin Subunit Inhibits 
p16INK4a-mediated Anoikis
To more directly evaluate the relationship between p16INK4-
mediated a5b1 upregulation and restoration of susceptibil-
ity to anoikis, we inhibited the expression of the a5 chain
in two independent p16INK4a-transfected clones by trans-
fecting an antisense a5 cDNA construct. As shown by
FACS® analysis, overexpression of a5 antisense cDNA re-
sulted in inhibition of a5 protein expression comparable to
p16INK4-negative wild-type or mock-transfected controls
(Fig. 7). Subsequent cell cycle distribution (Fig. 8, A and
B) and PARP cleavage analysis (Fig. 8 C) revealed that
downregulation of the a5 subunit by antisense transfection
resulted in almost complete inhibition of anoikis com-
pared with p16INK4a-positive controls. These data provide
direct evidence that p16INK4a-mediated upregulation of the
a5b1 fibronectin receptor is required for induction of
anoikis.
Discussion
Recent experimental evidence suggested additional func-
tions of p16INK4a, other than controlling the G1 checkpoint
of the cell cycle. (Chintala et al., 1997; Fåhraeus and Lane,
1999; Harada et al., 1999; Wolff and Naumann, 1999;
Zhang et al., 1999). The picture emerging from these stud-
ies envisions p16INK4a as a more general modulator of the
cellular phenotype via interactions with multiple cellular
targets. This notion is supported by some biochemical fea-
tures of p16INK4a, which imply biological functions in addi-
tion to cell cycle control: (a) the binary p16INK4a–Cdk4
complex exists in a 1:1 stoichiometry, but not all p16INK4a
molecules are complexed with Cdks, and a considerable
amount of free p16INK4a seems to be present in cells during
the entire cell cycle (Della Ragione et al., 1996); (b) in ad-
dition to nuclear localization, p16INK4a is also distributed in
the cytoplasm (Sano et al., 1998); (c) due to the extremely
Figure 6. Effects of fibronectin on anoikis. (A) 5 3 105 cells were
plated on polyHEMA dishes and incubated for 20 h with soluble
fibronectin (0.3 mg/ml) or laminin (0.15 mg/ml). Apoptotic cells
were subsequently quantitated by flow cytometry. Shown is the
mean 6 SEM of three independent experiments. (B) 5 3 105 cells
of Capan-1 clone p16/1 were plated on polyHEMA dishes and in-
cubated with the indicated concentrations of soluble fibronectin
and inhibitory anti-a5 antibody for 20 h. Apoptosis was detected
and quantitated by flow cytometry measuring the apoptotic pre-
G1 peaks. One representative of three experiments is shown.
Figure 7. Antisense-induced downregulation of the a5 integrin
chain. 1.5 3 107 cells of Capan-1 clone p16/1 and p16/2 were
cotransfected using lipofectamine with the vectors pCMV-59 a5/
antisense and pIRES1-hyg. After 4 d of selection in the presence
of 0.1 mg/ml hygromycin, cells were pooled and a5 expression was
detected by FACS® analysis using a monospecific antibody
against a5 integrin chain and immunoglobulins (Ig) as isotype
control. Demonstrated are the a5 expression levels of Capan-1
wild-type (wt), p16INK4a-transfected (p16/1), and p16INK4a plus a5
antisense cotransfected (p16/a5 as) Capan-1 clones. A represen-
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stable p16INK4a mRNA (half-life . 24 h) and protein (half-
life 8–18 h) (Serrano, 1997), p16INK4a is expressed con-
stantly during progression through the cell cycle, whereas
expression of other regulators of the G1 checkpoint, like
cyclin D1, is mainly restricted to the G1 phase (Soucek et
al., 1995).
In this study, we provide experimental evidence for yet
another novel biological function of the tumor suppressor
gene p16INK4a. Reconstituted expression of p16INK4a in hu-
man pancreatic cancer and other tumor cell lines confers
the capability to undergo anoikis, a central attribute spe-
cifically lost during malignant transformation of most epi-
thelial malignancies.
We chose pancreatic cancer cells as a suitable model to
investigate our hypothesis that p16INK4a might influence
anoikis for two reasons: (1) pancreatic cancer has the high-
est frequency of p16INK4a alterations of all human malig-
nancies (.90%) (Schutte et al., 1997) and (2) this tumor
is characterized by particular early and aggressive local
growth and metastasis (Rosewicz and Wiedenmann, 1997),
suggesting that failure to undergo anoikis might play a cru-
cial role in its tumor biology. The majority of pancreatic
cancers contain multiple genetic defects such as activation
of the oncogene K-ras and inactivation of the tumor sup-
pressor genes DPC4, p53, and p16INK4a (Rozenblum et al.,
1997; Mangray and King, 1998). The human pancreatic
cancer cell line Capan-1 represents a suitable in vitro
model because the genetic background of Capan-1 cells is
similar, if not identical, to human pancreatic cancer. Ca-
pan-1 cells express activated K-ras (Tsuchida et al., 1998),
mutated DPC4 (Grau et al., 1997), and p53 (Bouvet et al.,
1998), whereas p16INK4a is lost due to homozygous deletion
(Huang et al., 1996; Schutte et al., 1997).
Reintroduction of p16INK4a in Capan-1 cells significantly
inhibited anchorage-independent growth in soft agar.
These results, which can be explained either by p16INK4a-
induced G1 arrest or induction of apoptosis, are in agree-
ment with previous findings where ectopic p16INK4a ex-
pression was shown to suppress colony formation in vitro
in glioblastoma cells (Higashi et al., 1997) or in lung cancer
cells (Lee et al., 1998). Similar results were reported for
p16INK4a-mediated effects in vivo. Growth of p16INK4a xe-
nografts was inhibited in xenotransplants derived from co-
lon carcinoma (Spillare et al., 1996), human head and neck
squamous cancer (Rocco et al., 1998), and mesothelioma
(Frizelle et al., 1998). Surprisingly, and in contrast to pre-
viously published studies (Serrano, 1997), we observed a
complete loss of tumorigenicity in p16INK4a-transfected hu-
man pancreatic cancer cells. This phenomenon was at least
in part due to initiation of apoptosis upon xenotransplan-
tation in nude mice as detected by in situ TUNEL staining.
Since p16INK4a did not alter the rate of apoptosis in adher-
ent Capan-1 cells (data not shown), one possible trigger
for induction of apoptosis in p16INK4a-expressing cells
might be based on their loss of attachment to extracellular
matrix when injected into nude mice. Based on these re-
sults, we further pursued the hypothesis that p16INK4a spe-
cifically affected cellular anchorage dependence. Cellular
responses to loss of matrix contact were studied in detail
using the polyHEMA system as an in vitro approach to
study anoikis. In p16INK4a- transfected Capan-1 cells we
demonstrated a time-dependent induction of programmed
cell death after matrix detachment, i.e., anoikis, as evi-
denced by subdiploid DNA content, DNA fragmentation,
and cleavage of the mitochondrial PARP protein. In con-
trast, p16INK4a-negative parental or mock-transfected con-
trols revealed negligible amounts of anoikis.
To exclude a cell type–specific phenomenon, we investi-
gated whether p16INK4a-mediated anoikis could also be ob-
served in other epithelial cell systems derived from a dif-
ferent tissue context. Therefore, we stably transfected
p16INK4a into p16INK4a-negative cell lines from human liver
(SKHep1), human skin (NKI4), and canine kidney (MDCK).
In NKI4 cells the p16INK4a gene contains a point mutation
inducing a stop codon (Castellano et al., 1997). Like Ca-
pan-1 cells, SKHep1, MDCK, and NKI4 cells were all
negative in p16INK4a Western blot analyses using monospe-
cific human p16INK4a antibodies (Fig. 4 A). In all three
cell lines, we consistently observed induction of anoikis
upon reconstitution of p16INK4a expression. Therefore, the
p16INK4a-mediated induction of anoikis is not restricted to
pancreatic cancer cells, but appears to be operative in a va-
riety of cell types of different origin.
Because integrins have been implicated in regulation of
Figure 8. Effects of a5 integrin downregulation on p16INK4a-medi-
ated anoikis. 5 3 105 cells of control, p16INK4a-positive, or
p16INK4a-positive plus a5 antisense–transfected clones generated
as described in the legend to Fig. 7, were plated on polyHEMA-
coated dishes for 20 h and subsequently analyzed for cell cycle
distribution by flow cytometry. Shown is a representative cell cy-
cle distribution (A) and the mean 6 SEM of three independent
experiments (B). (C) PARP cleavage. After cultivation on poly-
HEMA, cell lysates were prepared and immunoblotted with an
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anoikis, we speculated that p16INK4a might regulate anoikis
via alteration of the cellular integrin composition. FACS®
analysis revealed expression of six different a and three
different b integrins in Capan-1 cells. However, the inte-
grin expression pattern between p16INK4a negative controls
and p16INK4a-transfected cells was very similar, with the
exception of a5, which was consistently overexpressed in
all p16INK4a independently transfected cell clones exam-
ined.
The a5 integrin subunit selectively associates with b1 to
form the  a5b1 fibronectin receptor. Although regulatory
effects on a5b1 fibronectin receptor expression have been
described for cytokines (Roberts et al., 1988; Huang and
Chakrabarty, 1994; Dedhar, 1989), hormones (Nakamura
et al., 1998), pharmacological substances (Symington et al.,
1989), and other integrins (Tomatis et al., 1999), the up-
regulation of a5b1 by a cell cycle–regulating tumor sup-
pressor gene observed in this study represents a novel and
unexpected finding. Even though incompletely under-
stood, a5b1 expression is generally regulated by various
molecular mechanisms such as transcriptional activation
(Delcommenne and Streuli, 1995), mRNA stability (Xu
and Clark, 1996), and translational control (Harwood et
al., 1999). Using a combined approach of immunoprecipi-
tation, Northern blotting, and nuclear run-on analysis, we
observed transcriptional induction of a5 upon reexpres-
sion of p16INK4a as a major cause for increased surface
membrane expression of the fibronectin receptor. As
there is currently no evidence for binding of p16INK4a to
DNA, a physical contact with the a5 promoter appears un-
likely. However, the a5 promoter contains consensus bind-
ing sites for different transcription factors such as SP1,
AP1, AP2, and ets (Birkenmeier et al., 1991). Therefore, it
appears possible, though speculative, that p16INK4a-medi-
ated transcriptional activation of a5 is transduced indi-
rectly through interaction of p16INK4a with other transcrip-
tion factors, as has recently been shown for interaction
with nuclear factor kB (Wolff and Naumann, 1999).
What is the biological significance of p16INK4a-mediated
upregulation of the a5b1 integrin? The a5b1 fibronectin re-
ceptor plays an important role for regulation of tumor
growth. Compared with their nontransformed counter-
parts,  a5b1 expression is frequently lost during malignant
transformation (Plantefaber and Hynes, 1989), a phenom-
enon that has been observed in human colonic (Stallmach
et al., 1992), mammary (Zutter et al., 1990), and pancreatic
cancer (Hall et al., 1991; Shimoyama et al., 1995). More-
over, loss of a5b1 integrin expression in CHO cells in-
creased tumorigenicity (Schreiner et al., 1991) in vivo. In
analogy, de novo expression of the a5b1 integrin has been
shown to reduce tumor formation as well as metastasis in
CHO cells (Giancotti and Ruoslahti, 1990), in K562 eryth-
roleukemia cells (Symington, 1990), and in HT29 colon
carcinoma cells (Stallmach et al., 1994; Schirner et al.,
1998; Schmidt et al., 1998). Independent of the in vitro sys-
tem examined, the amount of cellular a5b1 expression has
been consistently found to be of critical importance be-
cause it determines the extent of growth inhibition (Ruo-
slahti, 1994–95).
The a5b1 integrin, when not bound to fibronectin, trans-
mits a negative growth signal to the cell, which can be re-
verted by attachment to fibronectin (Juliano and Varner,
1993). For example, CHO cells do not undergo apoptosis
upon serum withdrawal when cells are attached to fi-
bronectin through a5b1 (Zhang et al., 1995). Moreover, the
fibronectin receptor was shown to convert survival signals
into death signals when dissociated from its ligand (Varner
et al., 1995, Frisch and Ruoslahti, 1997), a process that is
reflected when tumor cells lose contact with their original
tissue context. In this context, the amount of unligated cel-
lular a5b1 integrin expression is of critical importance be-
cause it determines the susceptibility to cell growth regula-
tion (Giancotti and Ruoslahti, 1990; Schreiner et al., 1991;
Varner et al., 1995). We demonstrated that restoration of
susceptibility to anoikis occurred in cells, which upregulate
the  a5b1  integrin upon p16INK4a reexpression. Further-
more, subsequent antisense-induced downregulation of
the  a5 subunit almost completely abolished p16INK4a-medi-
ated anoikis. Thus, upregulation of the fibronectin re-
ceptor represents the crucial key for induction of anoikis
upon reconstitution of p16INK4a. Accordingly, we observed
that cells that upregulate the fibronectin receptor upon
p16INK4a reexpression were protected from anoikis when
supplemented with the soluble form of the specific ligand
fibronectin under nonadherent conditions. This finding is
in agreement with previous reports showing antiapoptotic
effects of soluble fibronectin and other soluble extracellu-
lar matrix proteins on suspended cells (Bozzo et al., 1997;
Fukai et al., 1998). We provided three independent lines of
evidence to support the conclusion that p16INK4a-mediated
upregulation of unligated a5b1 accounts for the extent of
anoikis: (1) the anoikis- protective effect was specific for
fibronectin, whereas other ECM components, such as
laminin and collagen type IV, were ineffective; (2) the
anoikis-inhibitory effects of fibronectin were dose depen-
dent, with a maximal effect in the physiological range of
soluble fibronectin present in human plasma at z30 mg/dl
(Wu et al., 1993); and (3) treatment with an inhibitory
anti-a5 antibody, which disrupts the a5b1 integrin–fibro-
nectin interaction, abolished the anoikis-protective effect
of fibronectin. Therefore, the current results underline the
significance of fibronectin receptor occupation for cell sur-
vival and extend previous reports by demonstrating a
novel functional link between a nuclear tumor suppressor
gene and a membrane-bound integrin.
In conclusion, we presented evidence suggesting that
p16INK4a can restitute a less malignant phenotype by pro-
viding the protective machinery to control cell death upon
loss of cell–extracellular matrix contact. Aside from its in-
hibitory effects on cell cycle progression, these observa-
tions provide further rationale for ongoing strategies to
exploit reconstitution of p16INK4a as a therapeutic modality
for epithelial malignancies (Sandig et al., 1997; Rocco et
al., 1998).
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